Morocco’s first pharmaceutical factory, Cooper Pharma’s laboratory in Rwanda and East Africa, will be operational next July, announced Danny Mutembe, Cooper Pharma’s representative in Rwanda.
This pharmaceutical factory, whose construction had started in 2017, is one of the 21 agreements that were signed between Morocco and Rwanda in October 2016 during the visit of King Mohammed VI to the East African country.
“We plan to start production in the second quarter of this year. The project’s implementation rate is currently 70 percent,” said Danny Mutembe, quoted in the local press on Wednesday.
The plant, located in the Kigali Special Economic Zone on 20,000 square meters, will manufacture beta-lactam antibiotics next July, he said.
“The government has asked us to start with IV fluids (intravenous fluids) and so far construction work on line IV, valued at $ 2 million, is being finalized,” revealed the representative of Cooper Pharma.
Ultimately, the plant should help Rwanda to reduce expenditure on importing medicines by locally manufacturing beta-lactam antibiotics but also non-beta-lactam medicines, in line with local market needs and good manufacturing practices at an international level.
Cooper Pharma is a producer, distributor and exporter of pharmaceutical specialties. From a leader in Morocco, the laboratory is today a benchmark player in the Africa and Middle East region